116 related articles for article (PubMed ID: 28214870)
1. The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice.
Haruna T; Soga M; Morioka Y; Imura K; Furue Y; Yamamoto M; Hayakawa J; Deguchi M; Arimura A; Yasui K
Pharmacology; 2017; 99(5-6):259-267. PubMed ID: 28214870
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice.
Kim TH; Kim GD; Ahn HJ; Cho JJ; Park YS; Park CS
Life Sci; 2013 Oct; 93(15):516-24. PubMed ID: 23933131
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear.
Oka S; Yanagimoto S; Ikeda S; Gokoh M; Kishimoto S; Waku K; Ishima Y; Sugiura T
J Biol Chem; 2005 May; 280(18):18488-97. PubMed ID: 15749716
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation.
Mimura T; Oka S; Koshimoto H; Ueda Y; Watanabe Y; Sugiura T
Int Arch Allergy Immunol; 2012; 159(2):149-56. PubMed ID: 22652530
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
6. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Yuan XY; Ma HM; Li RZ; Wang RY; Liu W; Guo JY
Eur J Pharmacol; 2011 May; 658(2-3):263-9. PubMed ID: 21371468
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Jang AH; Kim TH; Kim GD; Kim JE; Kim HJ; Kim SS; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2011 Sep; 11(9):1271-7. PubMed ID: 21504802
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Kim TH; Kim GD; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice.
Wu G; Li L; Sung GH; Kim TW; Byeon SE; Cho JY; Park CW; Park HJ
J Ethnopharmacol; 2011 Mar; 134(2):504-9. PubMed ID: 21184821
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice.
Oka S; Wakui J; Ikeda S; Yanagimoto S; Kishimoto S; Gokoh M; Nasui M; Sugiura T
J Immunol; 2006 Dec; 177(12):8796-805. PubMed ID: 17142782
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice.
Ueda Y; Miyagawa N; Wakitani K
Life Sci; 2007 Jan; 80(5):414-9. PubMed ID: 17055000
[TBL] [Abstract][Full Text] [Related]
12. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Ahn HJ; Park YS; Park CS
J Pineal Res; 2009 Nov; 47(4):324-9. PubMed ID: 19817972
[TBL] [Abstract][Full Text] [Related]
14. Orally supplemented Lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice.
Shah MM; Miyamoto Y; Yamada Y; Yamashita H; Tanaka H; Ezaki T; Nagai H; Inagaki N
Microbiol Immunol; 2010 Sep; 54(9):523-33. PubMed ID: 20840151
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Cho JJ; Park YS; Park CS
Int Immunopharmacol; 2010 Oct; 10(10):1310-5. PubMed ID: 20728595
[TBL] [Abstract][Full Text] [Related]
16. α-Lipoic acid suppresses the development of DNFB-induced atopic dermatitis-like symptoms in NC/Nga mice.
Kim GD; Kim TH; Jang AH; Ahn HJ; Park YS; Park CS
Exp Dermatol; 2011 Feb; 20(2):97-101. PubMed ID: 21166725
[TBL] [Abstract][Full Text] [Related]
17. Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Kang JS; Youm JK; Jeong SK; Park BD; Yoon WK; Han MH; Lee H; Han SB; Lee K; Park SK; Lee SH; Yang KH; Moon EY; Kim HM
Int Immunopharmacol; 2007 Dec; 7(13):1589-97. PubMed ID: 17996668
[TBL] [Abstract][Full Text] [Related]
18. S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission.
Haruna T; Soga M; Morioka Y; Hikita I; Imura K; Furue Y; Yamamoto M; Imura C; Ikeda M; Yamauchi A; Deguchi M; Shichijo M; Arimura A; Yasui K
Pharmacology; 2015; 95(1-2):95-103. PubMed ID: 25721168
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of allergic contact dermatitis through the endocannabinoid system.
Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A
Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.
Ueda Y; Miyagawa N; Matsui T; Kaya T; Iwamura H
Eur J Pharmacol; 2005 Sep; 520(1-3):164-71. PubMed ID: 16153638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
